SCHEMBL5013794

SCHEMBL5013794

Cc1ccccc1Nc1ccccc1-c1c2nc(cc3ccc([nH]3)c(-c3ccccc3Nc3ccccc3C)c3nc(cc4ccc1[nH]4)C=C3)C=C2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.53
▸ STAT1 P42224 1/20 0.53
▸ KMT2A Q03164 4/20 0.37
▸ MEN1 O00255 3/20 0.37
▸ ERBB2 P04626 1/20 0.36
▸ TP53 P04637 1/20 0.35
▸ SLC2A1 P11166 1/20 0.35
▸ ALDH1A1 P00352 3/20 0.34
▸ HPGD P15428 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HSP90AA1 P07900 1/20 0.34
▸ HSP90AB1 P08238 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ BLM P54132 1/20 0.34
▸ SAE1 Q9UBE0 1/20 0.34
▸ UBA2 Q9UBT2 1/20 0.34
▸ PABPC1 P11940 1/20 0.33
▸ SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8689812 0.87 STAT3 (0.60) STAT3STAT1ALDH1A1HPGDGAA
SCHEMBL6081642 0.85 STAT3 (0.59) STAT3STAT1KMT2AMEN1TP53
SCHEMBL6081942 0.85 STAT3 (0.59) STAT3STAT1KMT2AMEN1ALDH1A1
SCHEMBL9514951 0.85 STAT3 (0.58) STAT3STAT1ALDH1A1HPGDSMN1; SMN2
SCHEMBL27579991 0.85 STAT3 (0.58) STAT3STAT1ALDH1A1HPGDGAA
SCHEMBL7260900 0.84 STAT3 (0.56) STAT3STAT1ALDH1A1HPGDSMN1; SMN2
SCHEMBL5011902 0.78 STAT3 (0.50) STAT3STAT1ALDH1A1KDM4ENPSR1
SCHEMBL311440 0.78 STAT3 (0.55) STAT3STAT1
SCHEMBL5011854 0.77 STAT3 (0.60) STAT3STAT1ALDH1A1HPGDKDM4E
SCHEMBL5011946 0.77 STAT1 (0.48) STAT3STAT1ALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7417142-B2 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, INC. (US) 2008-08-26 — — US disclosed
US-20050124596-A1 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2005-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124596-A1 Chiral porphyrins, chiral metalloporphyrins, and methods for synthesis of the same PPOX, PPIF, HMBS STAT3 2986/4885STAT1 3579/4885KMT2A 2709/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback